Omrix's Unattributed VC Round

Omrix raised a round of funding on October 23, 1998. Investors include Thuja Capital Management.

Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix's biosurgery product line includes prod…

Articles about Omrix's Unattributed VC Round: